A new cancer treatment experiment is using immune-stimulators to target tumors in mice. The experiment, held at Stanford University, has had remarkably encouraging results, according to New York Daily News. Scientists inject a combination of two immune boosters directly into solid mouse tumors. Doing this eliminated all traces of the specifically targeted cancer from the animal’s entire body, including metastases that were previously untreated. Senior author of the study, Dr. Ronald Levy told the Stanford Medicine News Center that the two agents together work to eliminate all other tumors in the body. “This approach bypasses the need to identify tumor-specific immune targets and doesn’t require wholesale activation of the immune system or customization of a patient’s immune cells,” he said, according to Daily News. One of the immune agents has already been approved for use in humans and the second one is currently involved in a lymphoma treatment trial. The study was replicated in 90 other mice and was successful in eradicating the tumors of 87 of them. The cancer did return in three of the animals, but the tumors regressed again after another round of immune treatment.
Thanks for reading InsideHook. Sign up for our daily newsletter and be in the know.
